Clinical impact of pre ‐treatment FDG‐PET/CT staging of primary ovarian‐, fallopian tube‐ and peritoneal cancer in women
ConclusionsFurther examinations of added findings by flourdeoxyglucose with positron emission tomography and computed tomography delayed time to start of treatment by median four days in women with newly diagnosed ovarian ‐, fallopian tube‐, or peritoneal cancer in a contemporary institution with fast track access to additional diagnostics. The clinical implications of this must be balanced against the gain of detecting unrecognized malignancy in 15 of 209 women (7.2%).
Source: Acta Obstetricia et Gynecologica Scandinavica - Category: OBGYN Authors: Sara Elisabeth Sponholtz,
Ole Mogensen,
Malene Grubbe Hildebrandt,
Pernille Tine Jensen Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Colon Cancer | Colorectal Cancer | Conferences | CT Scan | Fallopian Tube Cancer | OBGYN | Ovarian Cancer | Ovaries | Peritoneal Cancer | PET Scan | Women